Sporogenics filed a PCT patent on 10-Sep-2021 on ADHESION BARRIER COMPOSITION, METHODS OF FABRICATION AND USE THEREOF
Title (EN) ADHESION BARRIER COMPOSITION, METHODS OF FABRICATION AND USE THEREOF (FR) COMPOSITION DE BARRIÈRE ANTI-ADHÉRENCE, SES PROCÉDÉS DE FABRICATION ET SON UTILISATION Abstract (EN) …
Sporogenics was featured on the latest issue on an online UK magazine
Sporogenics was featured on the latest issue on an online UK magazine, please click below link to read more about Sporogenics’s story and aspiration. https://ghp-news.com/issues/q1-2021/42/
Sporogenics is honored to be the recipient of JLabs Award
Sporogenics is honored to be the recipient of JLabs Award at MedTech Innovator Asia Pacific 2020 Grand Final for 1 year residency at Johnson & …
Sporogenics made it into the Grand Finals!
Please support us to join the quest to improve surgical outcomes by preventing postsurgical adhesion! https://medtechinnovator.org/medtech-innovator-asia-pacific-finalists-2020/
Sporogenics will be participating APACMED virtual conference 2020 to share a 5min pitch!!!
Check the website for details: https://www.apacmedvirtualforum.com
Sporogenics is among 20 selected for MedTech Innovator Asia Pacific 2020 Accelerator Cohort
Sporogenics participated in MedTech Innovator APAC 2020
Among over 180 submissions, Sporogenics is delighted to be selected as one of the 40 medtech startups for an online pitch session on 26 May …
Baxter picks up Sanofi’s Seprafilm adhesion barrier for $350M
Dec 2, 2019 Baxter International said Monday it plans to acquire Sanofi’s surgical products unit Seprafilm and related assets for $350 million in cash, confirming …